Results 61 to 70 of about 85,538 (123)

Subset analyses of CSM in matched cohort between cytoreductive nephrectomy versus no surgery using univariate Cox proportional hazard model.

, 2019
Subset analyses of CSM in matched cohort between cytoreductive nephrectomy versus no surgery using univariate Cox proportional hazard model.
Wenqi Wu (22612), Zhijian Zhao (389825), Guohua Zeng (288129), Yongda Liu (6260804), Xiaolu Duan (331534)   +4 more
core   +1 more source

Additional file 1 of Multicenter randomized trial of deferred cytoreductive nephrectomy in synchronous metastatic renal cell carcinoma receiving checkpoint inhibitors: the NORDIC-SUN-Trial

Additional file 1. Checklist for SPIRIT guidelines.
Iisager, Laura, Ahrenfeldt, Johanne, Donskov, Frede, Ljungberg, Börje, Bex, Axel, Lund, Lars, Lyskjær, Iben, Fristrup, Niels   +7 more
openaire   +1 more source

A 73-Year-Old Man With a Late Isolated Brain Metastasis of Clear Cell Renal Cell Carcinoma Following a Durable Complete Response to Lenvatinib-Pembrolizumab, Resulting in Deferred Cytoreductive Nephrectomy. [PDF]

Am J Case Rep
Ito F, Kobayashi K, Hayashi G, Kamijo S, Fujita T.   +4 more
europepmc   +1 more source

Multidisciplinary management of metastatic renal cell carcinoma: a narrative review. [PDF]

Transl Androl Urol
Fribourg-Liendo RA, Kothari A, Yip W.
europepmc   +1 more source

Evolving role of cytoreductive nephrectomy in metastatic renal cell carcinoma of variant histology

PURPOSE OF REVIEW: Summarize current evidence for cytoreductive nephrectomy in patients with metastatic renal cell carcinoma (mRCC) of variant histology.
Karam J.A., Alhalabi O., Tannir N.M.
core  

Effect of Treatment Sequencing of Cytoreductive Nephrectomy on Overall Survival Outcomes in Patients Receiving Immunotherapy for Metastatic Renal Cell Carcinoma. [PDF]

Cureus
Zamani A, Cohn H, Moser AM, Michael Z, Krinock MJ, Fung G, Shao YF, Ginsburg KB.   +7 more
europepmc   +1 more source

The Prognostic Value of Clinical and Pathological Response to Neoadjuvant Therapy in Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Systematic Review and Clinical Implications. [PDF]

Cancers (Basel)
Chernysheva D, Hernandez-Peñalver P, Maroto P, Palou J, Breda A, Rodriguez-Faba O.   +5 more
europepmc   +1 more source

Local treatment for metastatic and primary sites in metastatic renal cell carcinoma in the combination immunotherapy era: a narrative review. [PDF]

Int J Clin Oncol
Abe J, Murashima T, Kojima S, Ueno T, Takei A, Nakai N, Akioka T, Kamoto T, Sawada A.   +8 more
europepmc   +1 more source

Neoadjuvant therapies for clear cell renal cell carcinoma: review of current evidence and future applications. [PDF]

World J Urol
McMaster T, McVeigh N, Chen DC, Al-Khanaty A, Sandhu K, Carll J, Woon DT, Murphy DG, Lawrentschuck N, Au L, Ali M, Siva S, Perera M.   +12 more
europepmc   +1 more source

The effect of cytoreductive nephrectomy on survival in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors. [PDF]

North Clin Istanb
Bilgetekin I, Ozturk E, Karacin C, Basal FB, Akdagcik Z, Oksuzoglu B.   +5 more
europepmc   +1 more source